Clinical Trial Update: An Investigational Drug Study to Assess Weight Loss in Obese and Overweight Patients (0364-037)(TERMINATED) [Phase 3]

View source ↗

Summary

This update notes that a Phase 3 trial evaluating an investigational obesity drug sponsored by Merck Sharp & Dohme LLC has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Investigational obesity drug

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Obesity | Phase 3 | Status: TERMINATED